Cargando…
Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy
Next-generation sequencing-based comprehensive genome profiling (CGP) testing, OncoGuide NCC Oncopanel System, and FoundationOne CDx Cancer Genomic Profile have been covered by the Japanese national health insurance system since June 2019. Because CGP was initially developed to enroll patients into...
Autores principales: | Yoshii, Yumi, Okazaki, Shunsuke, Takeda, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399872/ https://www.ncbi.nlm.nih.gov/pubmed/34440540 http://dx.doi.org/10.3390/life11080796 |
Ejemplares similares
-
New Era for Next-Generation Sequencing in Japan
por: Takeda, Masayuki, et al.
Publicado: (2019) -
Current status of molecular diagnostic approaches using liquid biopsy
por: Takahashi, Kenji, et al.
Publicado: (2023) -
Next-generation sequencing in liquid biopsy: cancer screening and early detection
por: Chen, Ming, et al.
Publicado: (2019) -
Power and Promise of Next-Generation Sequencing in Liquid Biopsies
and Cancer Control
por: Wu, Ting-Miao, et al.
Publicado: (2020) -
Molecular profile of liquid biopsies: next generation biomarkers to improve lung cancer treatment
por: Bianchi, Fabrizio
Publicado: (2015)